Quantcast
Last updated on April 23, 2014 at 13:54 EDT

Latest Novo Nordisk Stories

2013-04-22 04:21:10

CAMBRIDGE, England, April 22, 2013 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company, announced today an agreement in therapeutic antibody discovery. Novo Nordisk has been granted a non-exclusive licence to Kymab's proprietary Kymouse(TM) human antibody discovery platform to discover, develop and commercialise therapeutic monoclonal antibody drugs for human diseases. The licence provides Novo Nordisk with access to the Kymouse HK and Kymouse HL...

2013-04-19 12:27:34

Diabetes leader bolsters presence in N.J. with 731,000-square-foot office building in Plainsboro, N.J. PLAINSBORO, N.J., April 19, 2013 /PRNewswire/ -- Advancing its commitment to patients and New Jersey, Novo Nordisk (NYSE: NVO) today unveiled its new U.S. headquarters. Located in Mercer County in Plainsboro, N.J., the world-class building is the result of a $225 million redevelopment project, which utilized an existing structure and sustainable materials to limit environmental...

2013-04-17 08:20:41

Increased Demand for Compliance Solutions Spurs International Growth DUBAI, United Arab Emirates, April 17, 2013 /PRNewswire/ -- TRACE International, the global anti-bribery business association that works with multi-national companies to enhance transparency and compliance in business, today announced the opening of an office in Dubai's Silicon Oasis. The new office significantly expands TRACE's reach in the Middle East, Asia and Africa, where demand for TRACE tools and services...

2013-04-17 04:21:27

New Sponsors, Partners and Supporters of the GSMA mHealth Grand Tour Will Help Raise Awareness of Diabetes and the Need for mDiabetes Solutions LONDON, April 17, 2013 /PRNewswire/ -- The GSMA today announced that a number of new organisations, including ANT+, Orange, Team Blood Glucose (TeamBG) and Team Novo Nordisk, will take part in the GSMA mHealth Grand Tour cycle ride in September 2013. Through the collaboration of all sponsors, partners and supporters, the mHealth Grand Tour...

2013-04-15 08:29:51

-- In collaboration with its partners--Bayer Healthcare, Medtronic, and Novo Nordisk--JDRF's Adult Type 1 Pak is a sling-style bag with resources for newly-diagnosed adults -- NEW YORK, April 15, 2013 /PRNewswire-USNewswire/ -- JDRF announced today that it has created a new resource for adults newly diagnosed with type 1 diabetes (T1D). The Adult Type 1 Pak is a sling-style bag that will include important resources and information to educate, support, and inspire adults newly diagnosed...

2013-04-05 08:23:44

Enter today for a chance to win a trip to the 2013 IndyCar® Series finale BIRMINGHAM, Ala., April 5, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and IZOD IndyCar Series driver Charlie Kimball today kicked off a new contest asking people to support Charlie by encouraging their friends and family to join the Race with Insulin(®) crew. Now through September 15, by sharing Kimball's story about the importance of team support with two or more friends or...

2013-04-04 08:29:38

NEW YORK, April 4, 2013 /PRNewswire-USNewswire/ -- JDRF is pleased to announce that Novo Nordisk, a global healthcare company with 90 years of innovation and leadership in diabetes care, has become the official national presenting sponsor of the JDRF Ride to Cure Diabetes. The annual, nationwide fundraising event brings together cyclists of all levels from around the world to raise much needed funds toward type 1 diabetes (T1D) research and participate in a destination cycling experience....

2013-03-27 08:32:46

DUBLIN, March 27, 2013 /PRNewswire/ -- Research and Markets announces the addition of "China Insulin Industry Report, 2012-2015 [http://www.researchandmarkets.com/research/b6c5bv/china_insulin ]" to its catalogue. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Due to high technological content and entry barriers, Chinese insulin market is monopolized by foreign corporations. In 2011, the combined market share of the three world-renowned...

2013-03-07 08:28:47

America's favorite author, entrepreneur, and cook shares her diabetes management changes inspiring others to make same commitment PRINCETON, N.J., March 7, 2013 /PRNewswire/ -- Novo Nordisk, in partnership with American cooking star Paula Deen, is giving those with type 2 diabetes, and their loved ones, a chance to walk in Paula's footsteps this year beginning with the launch of the Seeing Diabetes in a New Light(®) contest and continuing through a variety of...

2013-02-19 08:32:45

Global leader in diabetes care recognizes anniversary of Canadian roots MISSISSAUGA, ON, Feb. 19, 2013 /CNW/ - Danish-based pharmaceutical company Novo Nordisk is celebrating the 90(th) anniversary of when diabetes patients were first treated with the company's insulin. With its Canadian headquarters in Mississauga, the company is focused on developing new and better treatments for people with diabetes. Now the world's largest diabetes care company, Novo Nordisk provides therapeutic...